Bu sayfada
BHC Bausch Health Companies Inc. Common Stock
NYSE · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Tem 30, 2026
$5,80
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$4,3352 haftanın en düşüğü
$8,0052 haftanın en yükseği
Piyasa Değeri (MRQ)
$2.17B
P/E (TTM)
-2.0
Hisse Başına Kâr (TTM)
$-2.96
Gelir (TTM)
$10.85B
rozetleriniz
52 Haftlık Aralık
$4–$8
Analist Derecelendirmesi
HOLD
Fiyat Hedefi
$8
P/E
-2.0
ROE
86.6%
Net Kâr Marjı
-10.1%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
BHC Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$5.80
Piyasa Değeri (MRQ)
$2.17B
P/E (TTM)
-2.0
Hisse Başına Kâr (TTM)
$-2.96
Gelir (TTM)
$10.85B
ROE (TTM)
86.6%
D/E Borç/Özsermaye (MRQ)
-11.7
52 Haftlık Aralık
$4–$8
BHC Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 16 Ekim 2000 | 2-for-1 | İleri |
| 20 Ocak 2000 | 2-for-1 | İleri |
| 17 Ocak 1996 | 3-for-1 | İleri |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$10.27B2016-12-31 → 2025-12-31
Hisse Başına Kâr$0.422016-12-31 → 2025-12-31
Serbest Nakit Akışı$1.00B2016-12-31 → 2025-12-31
Net kar marjı-10.1%2016-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | BHC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -2.05Y ort. ≈-14.2 | ≈-14.2 | · | · | |
| F/S (TTM) | 0.25Y ort. ≈0.5 | ≈0.5 | · | · | |
| F/D (MRQ) | -1.25Y ort. ≈-21.3 | ≈-21.3 | · | · | |
| EV / EBITDA | 11.95Y ort. ≈34.6 | ≈34.6 | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | 1.55Y ort. ≈2.9 | ≈2.9 | · | · | |
| Fiyat / Nakit Akışı (TTM) | 1.25Y ort. ≈2.1 | ≈2.1 | · | · | |
| EV / Revenue (EV / Gelir) | 2.15Y ort. ≈2.8 | ≈2.8 | · | · | |
| EV / FCF | 21.65Y ort. ≈14.9 | ≈14.9 | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | -0.4 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | BHC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | 8.1%5Y ort. ≈11.1% | ≈11.1% | · | · | |
| EBITDA Margin (FAVÖK Marjı) | 17.7%5Y ort. ≈11.1% | ≈11.1% | · | · | |
| Vergi Öncesi Kar Marjı (TTM) | -6.7%5Y ort. ≈-2.6% | ≈-2.6% | · | · | |
| Net Kâr Marjı (TTM) | -10.1%5Y ort. ≈-3.9% | ≈-3.9% | · | · | |
| ROA (TTM) | -4.2%5Y ort. ≈-1.2% | ≈-1.2% | · | · | |
| ROE (TTM) | 86.6%5Y ort. ≈-65.9% | ≈-65.9% | · | · | |
| ROIC | 2.9%5Y ort. ≈2.5% | ≈2.5% | · | · |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | BHC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | -11.75Y ort. ≈-64.0 | ≈-64.0 | · | · | |
| Cari Oran (MRQ) | 1.45Y ort. ≈1.2 | ≈1.2 | · | · | |
| Quick Ratio (Cari Oran) | 0.95Y ort. ≈0.6 | ≈0.6 | · | · | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | -11.25Y ort. ≈-63.3 | ≈-63.3 | · | · |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | BHC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 6.7%5Y ort. ≈5.2% | ≈5.2% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 8.1%5Y ort. ≈5.2% | ≈5.2% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 5.0% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | BHC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.45Y ort. ≈0.3 | ≈0.3 | · | · | |
| Receivables Turnover (Alacak Devir Hızı) | 4.65Y ort. ≈4.7 | ≈4.7 | · | · | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$505.7K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
Yıllıklaştırılmış Ödeme≈$4.00
| Ex-tarihi | Miktar | Para Birimi | Temettü Verimi |
|---|---|---|---|
| Kas 10, 2010 | $1,00 | USD | ≈5.0% |
| Ağu 30, 2010 | $0,10 | USD | ≈1.6% |
| May 28, 2010 | $0,10 | USD | ≈2.4% |
| Mar 4, 2010 | $0,09 | USD | ≈4.8% |
| Kas 30, 2009 | $0,09 | USD | ≈7.1% |
| Ağu 28, 2009 | $0,09 | USD | ≈7.3% |
| May 13, 2009 | $0,09 | USD | ≈11.2% |
| Mar 6, 2009 | $0,38 | USD | ≈13.9% |
| Ara 19, 2008 | $0,38 | USD | ≈16.6% |
| Ağu 21, 2008 | $0,38 | USD | ≈14.9% |
| May 20, 2008 | $0,38 | USD | ≈12.3% |
| Mar 25, 2008 | $0,38 | USD | ≈13.8% |
| Kas 16, 2007 | $0,38 | USD | ≈12.7% |
| Ağu 16, 2007 | $0,38 | USD | ≈10.5% |
| May 18, 2007 | $0,38 | USD | ≈6.6% |
| Mar 22, 2007 | $0,38 | USD | ≈5.8% |
| Oca 8, 2007 | $0,50 | USD | ≈4.9% |
| Kas 20, 2006 | $0,13 | USD | ≈5.8% |
| Ağu 16, 2006 | $0,13 | USD | ≈5.5% |
| May 19, 2006 | $0,13 | USD | ≈3.0% |
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-1.8%
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | $1.26 | $1.05 | 20.3% | |
| 31 Mart 2026 | $0.78 | $0.69 | 12.3% | |
| 31 Aralık 2025 | $1.10 | $1.28 | -13.9% | |
| 30 Eylül 2025 | $1.16 | $1.13 | 2.6% | |
| 30 Haziran 2025 | $0.91 | $0.98 | -7.1% | |
| 31 Mart 2025 | $0.60 | $0.80 | -25.1% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.27B | $9.62B | $8.76B | $8.12B | $8.43B | $8.03B | $8.60B | $8.38B | $8.72B | $9.67B | $10.45B | $8.21B | |
| Cost of Revenue | · | · | · | · | · | · | · | · | $2.51B | $2.57B | $2.53B | $2.18B | |
| SG&A Expense | $3.44B | $3.30B | $2.92B | $2.62B | $2.62B | $2.37B | $2.55B | $2.47B | $2.58B | $2.81B | $2.70B | $2.03B | |
| Operating Expenses | $8.45B | $8.08B | $7.79B | $7.67B | $7.98B | $7.35B | $8.80B | $10.76B | $8.62B | $10.24B | $8.92B | $6.21B | |
| Operating Income | $1.81B | $1.55B | $963M | $454M | $450M | $676M | $-203M | $-2.38B | $102M | $-566M | $1.53B | $2.00B | |
| Interest Income | $48M | $33M | $26M | $14M | $7M | $13M | $12M | $11M | $12M | $8M | $4M | $5M | |
| Other Non-op | $-142M | $-247M | $-28M | $-35M | $-373M | $-502M | $-1.43B | $20M | $348M | $-73M | $-295M | $263M | |
| Pretax Income | $367M | $167M | $-390M | $-129M | $-1.02B | $-934M | $-1.84B | $-4.15B | $-1.74B | $-2.44B | $-155M | $1.05B | |
| Income Tax | $247M | $239M | $221M | $83M | $-87M | $-375M | $-54M | $-10M | $-4.14B | $-27M | $133M | $174M | |
| Net Income | $157M | $-46M | $-592M | $-225M | $-948M | $-560M | $-1.79B | $-4.14B | $2.40B | $-2.41B | $-288M | $880M | |
| EPS (Basic) | $0.42 | $-0.13 | $-1.62 | $-0.62 | $-2.64 | $-1.58 | $-5.08 | $-11.81 | $6.86 | $-6.94 | $-0.85 | $2.63 | |
| EPS (Diluted) | $0.42 | $-0.13 | $-1.62 | $-0.62 | $-2.64 | $-1.58 | $-5.08 | $-11.81 | $6.83 | $-6.94 | $-0.85 | $2.58 | |
| Shares (Basic) | 370,900,000 | 368,000,000 | 364,900,000 | 362,000,000 | 358,900,000 | 355,000,000 | 352,100,000 | 351,300,000 | 350,200,000 | 347,300,000 | 342,700,000 | 335,400,000 | |
| Shares (Diluted) | 375,000,000 | 368,000,000 | 364,900,000 | 362,000,000 | 358,900,000 | 355,000,000 | 352,100,000 | 351,300,000 | 351,800,000 | 347,300,000 | 342,700,000 | 341,500,000 | |
| EBITDA | $1.81B | $1.55B | $963M | $454M | $450M | $676M | $-203M | $-2.38B | $102M | $-566M | $1.53B | $2.04B |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.31B | $1.18B | $947M | $564M | $582M | $605M | $3.24B | $721M | $720M | $542M | $597M | $323M | |
| Receivables | $2.35B | $2.14B | $2.00B | $1.79B | $1.77B | $1.58B | $1.84B | $1.86B | $2.13B | $2.52B | $2.69B | $2.08B | |
| Inventory | $1.63B | $1.59B | $1.54B | $1.09B | $993M | $1.09B | $1.11B | $934M | $1.05B | $1.06B | $1.26B | $889M | |
| Prepaid Expense | $852M | $838M | $1.09B | $776M | $720M | $855M | $779M | $689M | $771M | $696M | $963M | $651M | |
| Current Assets | $6.16B | $5.77B | $5.60B | $4.25B | $5.61B | $5.34B | $6.97B | $4.21B | $4.75B | $5.08B | $5.51B | $4.13B | |
| PP&E (Net) | $2.07B | $1.78B | $1.71B | $1.60B | $1.60B | $1.57B | $1.47B | $1.35B | $1.40B | $1.31B | $1.44B | $1.31B | |
| PP&E (Gross) | $4.50B | $3.92B | $3.79B | $3.52B | $3.42B | $3.35B | $3.11B | $2.88B | $2.83B | $2.51B | $2.63B | $2.29B | |
| Accum. Depreciation | $2.42B | $2.14B | $2.08B | $1.92B | $1.82B | $1.78B | $1.64B | $1.52B | $1.43B | $1.20B | $1.18B | $978M | |
| Goodwill | $11.27B | $11.09B | $11.18B | $11.55B | $12.46B | $13.04B | $13.13B | $13.14B | $15.59B | $15.79B | $18.55B | $9.36B | |
| Intangibles | $4.64B | $5.55B | $6.46B | $5.80B | $6.95B | $8.45B | $10.20B | $12.00B | $15.21B | $18.88B | $23.08B | $11.28B | |
| Other Non-current Assets | $378M | $363M | $307M | $326M | $340M | $664M | $411M | $109M | $111M | $184M | $224M | $167M | |
| Total Assets | $26.37B | $26.52B | $27.35B | $25.69B | $29.20B | $31.20B | $33.86B | $32.49B | $37.50B | $43.53B | $48.97B | $26.30B | |
| Accounts Payable | $600M | $589M | $719M | $521M | $407M | $337M | $503M | $411M | $365M | $324M | $434M | $398M | |
| Accrued Liabilities | $3.34B | $3.49B | $3.13B | $2.99B | $4.79B | $4.58B | $4.51B | $3.20B | $3.69B | $3.23B | $3.86B | $2.16B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | $6M | $16M | $6M | |
| Current Liabilities | $4.18B | $6.75B | $4.30B | $3.94B | $5.20B | $4.91B | $6.25B | $3.84B | $4.27B | $3.61B | $5.31B | $2.71B | |
| Capital Leases | $167M | $165M | $148M | $184M | $214M | $227M | $240M | · | · | · | · | · | |
| Deferred Tax | $147M | $128M | $163M | $202M | $529M | $528M | $705M | $885M | $1.18B | $5.43B | $5.90B | $2.22B | |
| Other Non-current Liabilities | $793M | $713M | $776M | $741M | $653M | $1.01B | $851M | $581M | $526M | $486M | $185M | $197M | |
| Total Liabilities | $25.99B | $26.84B | $27.43B | $25.43B | $29.24B | $30.59B | $32.73B | $29.68B | $31.55B | $40.27B | $42.94B | $20.90B | |
| Long-term Debt | $20.82B | $21.62B | $22.39B | $20.77B | $22.65B | $23.93B | $25.89B | $24.30B | $25.44B | $29.85B | $31.09B | $15.23B | |
| Total Debt | $20.82B | $21.62B | $22.39B | $20.77B | $22.65B | $23.93B | $25.89B | $24.30B | $25.44B | $29.85B | $31.10B | $15.26B | |
| Common Stock | $10.52B | $10.49B | $10.42B | $10.39B | $10.32B | $10.23B | $10.17B | $10.12B | $10.09B | $10.04B | $9.90B | $8.35B | |
| Retained Earnings | $-9.67B | $-9.82B | $-9.78B | $-9.19B | $-8.96B | $-8.01B | $-7.45B | $-5.66B | $-2.73B | $-5.13B | $-2.75B | $-2.40B | |
| AOCI | $-1.76B | $-2.18B | $-1.88B | $-2.06B | $-1.92B | $-2.13B | $-2.09B | $-2.14B | $-1.90B | $-2.11B | $-1.54B | $-916M | |
| Stockholders' Equity | $-554M | $-1.28B | $-1.02B | $-692M | $-106M | $535M | $1.06B | $2.73B | $5.85B | $3.15B | $5.91B | $5.28B | |
| Liabilities + Equity | $26.37B | $26.52B | $27.35B | $25.69B | $29.20B | $31.20B | $33.86B | $32.49B | $37.50B | $43.53B | $48.97B | $26.30B | |
| Shares Outstanding | 370,531,987 | 367,843,058 | 365,238,917 | 361,898,846 | 359,405,748 | 355,422,347 | 352,562,636 | 349,871,102 | 348,708,567 | 347,821,606 | 342,926,531 | 334,402,964 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.21B | $1.27B | $1.26B | $1.39B | $1.55B | $1.82B | $2.08B | $2.82B | $2.86B | $2.87B | $2.47B | $1.61B | |
| Stock-based Comp | $216M | $150M | $132M | $126M | $128M | $105M | $102M | $87M | $87M | $165M | $140M | $78M | |
| Deferred Tax | $132M | $69M | $6M | $-188M | $-36M | $-599M | $-182M | $-337M | $-4.31B | $-268M | $56M | $23M | |
| Restructuring | · | · | · | · | · | $22M | $31M | $22M | $52M | $132M | $362M | $382M | |
| Operating Cash Flow | $1.40B | $1.60B | $1.03B | $-728M | $1.43B | $1.11B | $1.50B | $1.50B | $2.29B | $2.09B | $2.26B | $2.31B | |
| CapEx | $397M | $337M | $215M | $218M | $269M | $302M | $270M | $157M | $171M | $235M | $235M | $292M | |
| Investing Cash Flow | $-595M | $-454M | $-2.15B | $-303M | $409M | $-261M | $-419M | $-196M | $2.89B | $-125M | $-15.58B | $-100M | |
| Debt Issued | $10.55B | $661M | $3.29B | $6.84B | $2.10B | $3.46B | $5.96B | $8.94B | $9.42B | $1.22B | $17.82B | $1.63B | |
| Net Debt Issued | $-637M | $-799M | $1.58B | $-1.01B | $-1.34B | $-2.19B | $1.55B | $-1.16B | $-4.78B | $-1.22B | $15.76B | $-2.26B | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | $0 | $1.43B | $0 | |
| Stock Repurchased | · | · | · | · | · | · | · | · | $0 | $0 | $72M | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $0 | $0 | $1.36B | $0 | |
| Financing Cash Flow | $-742M | $-868M | $1.48B | $-474M | $-1.51B | $-2.29B | $1.44B | $-1.35B | $-4.96B | $-1.96B | $13.62B | $-2.46B | |
| Net Change in Cash | $124M | $239M | $371M | $-1.53B | $303M | $-1.43B | $2.52B | $-74M | $255M | $-55M | $274M | · | |
| Taxes Paid | $163M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.00B | $1.26B | $817M | $-946M | $1.16B | $809M | $1.23B | $1.34B | $2.12B | $1.85B | $1.97B | $2.00B |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 17.7% | 16.1% | 11.0% | 5.6% | 5.3% | 8.4% | -2.4% | -28.4% | 1.2% | -5.9% | 14.6% | 24.7% | |
| Net Margin | 1.5% | -0.48% | -6.8% | -2.8% | -11.2% | -7.0% | -20.7% | -49.5% | 27.6% | -24.9% | -2.8% | 11.0% | |
| Pretax Margin | 3.6% | 1.7% | -4.5% | -1.6% | -12.1% | -11.6% | -21.4% | -49.6% | -20.0% | -25.2% | -1.5% | 13.2% | |
| EBITDA Margin | 17.7% | 16.1% | 11.0% | 5.6% | 5.3% | 8.4% | -2.4% | -28.4% | 1.2% | -5.9% | 14.6% | 24.7% | |
| ROA | 0.59% | -0.17% | -2.2% | -0.82% | -3.1% | -1.7% | -5.4% | -11.8% | 5.9% | -5.2% | -0.76% | 3.4% | |
| ROE | -17.1% | 4.0% | 69.1% | 56.4% | -442.0% | -70.0% | -93.9% | -114.0% | 53.4% | -53.1% | -5.1% | 17.5% | |
| ROIC | 2.9% | -3.3% | 7.1% | 3.7% | 1.8% | 1.7% | -0.73% | -8.8% | -0.45% | -1.7% | 7.6% | 8.3% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 0.9 | 1.3 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.4 | 1.0 | 1.5 | |
| Quick Ratio | 0.9 | 0.5 | 0.7 | 0.6 | 0.5 | 0.4 | 0.8 | 0.7 | 0.7 | 0.8 | 0.6 | 0.9 | |
| Debt / Equity | -37.6 | -16.9 | -21.9 | -30.0 | -213.7 | 44.7 | 24.4 | 8.9 | 4.4 | 9.5 | 5.3 | 2.9 | |
| LT Debt / Equity | -37.2 | -14.8 | -21.5 | -29.4 | -213.7 | 44.7 | 23.2 | 8.8 | 4.3 | 9.5 | 5.1 | 2.9 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | 2.4 | 2.2 | 2.4 | 2.4 | |
| Receivables Turnover | 4.6 | 4.7 | 4.6 | 4.6 | 5.0 | 4.7 | 4.6 | 4.2 | 3.8 | 3.7 | 4.4 | 4.4 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-1.50 | $-3.48 | $-2.80 | $-1.91 | $-0.29 | $1.51 | $3.02 | $7.81 | $16.77 | $9.06 | $17.24 | $15.89 | |
| Revenue / Share | $27.38 | $26.15 | $24.00 | $22.44 | $23.50 | · | $24.43 | $23.85 | $24.80 | $27.85 | $30.48 | $24.20 | |
| Cash Flow / Share | $3.73 | $4.34 | $2.83 | $-2.01 | $3.97 | · | $4.26 | $4.27 | $6.51 | $6.01 | $6.42 | $6.72 | |
| Cash / Share | $3.53 | $3.21 | $2.59 | $1.56 | $1.62 | $1.70 | $9.20 | $2.06 | $2.06 | $1.56 | $1.74 | $0.96 | |
| EPS (TTM) | $0.42 | $-0.13 | $-1.62 | $-0.62 | $-2.64 | $-1.58 | $-5.08 | $-11.81 | $6.83 | $-6.94 | $-0.85 | $2.58 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 6.7% | 9.9% | 7.8% | -3.7% | 5.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 8.1% | 4.5% | 2.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.0% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10.27B | $9.62B | $8.76B | $8.12B | $8.43B | $8.03B | $8.60B | $8.38B | $8.72B | $9.67B | $10.45B | $8.21B | |
| Net Income TTM | $157M | $-46M | $-592M | $-225M | $-948M | $-560M | $-1.79B | $-4.14B | $2.40B | $-2.41B | $-288M | $880M | |
| Market Cap | $2.58B | $2.96B | $2.93B | $2.27B | $9.92B | $7.39B | $10.55B | $6.46B | $7.25B | $5.05B | $34.86B | $47.86B | |
| Enterprise Value | $22.08B | $23.40B | $24.37B | $22.47B | $32.00B | $30.71B | $33.20B | $30.05B | $31.97B | $34.36B | $65.37B | $62.79B | |
| P/E | 16.5 | -62.0 | -5.0 | -10.1 | -10.5 | -13.2 | -5.9 | -1.6 | 3.0 | -2.1 | -119.6 | 55.5 | |
| P/S | 0.3 | 0.3 | 0.3 | 0.3 | 1.2 | 0.9 | 1.2 | 0.8 | 0.8 | 0.5 | 3.3 | 5.8 | |
| P/B | -4.6 | -2.3 | -2.9 | -3.3 | -93.6 | 13.8 | 9.9 | 2.4 | 1.2 | 1.6 | 5.9 | 9.0 | |
| P / Cash Flow | 1.8 | 1.9 | 2.8 | -3.1 | 7.0 | 6.7 | 7.0 | 4.3 | 3.2 | 2.4 | 15.8 | 20.9 | |
| P / FCF | 2.6 | 2.4 | 3.6 | -2.4 | 8.6 | 9.1 | 8.6 | 4.8 | 3.4 | 2.7 | 17.7 | 23.9 | |
| EV / EBITDA | 12.2 | 15.1 | 25.3 | 49.5 | 71.1 | 45.4 | -163.6 | -12.6 | 313.4 | -60.7 | 42.8 | 30.8 | |
| EV / FCF | 22.0 | 18.6 | 29.8 | -23.8 | 27.7 | 38.0 | 27.0 | 22.4 | 15.1 | 18.6 | 33.3 | 31.3 | |
| EV / Revenue | 2.2 | 2.4 | 2.8 | 2.8 | 3.8 | 3.8 | 3.9 | 3.6 | 3.7 | 3.6 | 6.3 | 7.7 | |
| Earnings Yield | 6.0% | -1.6% | -20.2% | -9.9% | -9.6% | -7.6% | -17.0% | -63.9% | 32.9% | -47.8% | -0.84% | 1.8% |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.85B | $2.52B | $2.80B | $2.68B | $2.53B | $2.26B | $2.56B | $2.51B | $2.40B | $2.15B | $2.41B | $2.24B | $2.17B | $1.94B | $2.19B | $2.05B | |
| SG&A Expense | $907M | $861M | $882M | $795M | $894M | $867M | $820M | $850M | $832M | $794M | $766M | $715M | $711M | $725M | $666M | $661M | |
| Operating Expenses | $2.11B | $3.47B | $2.32B | $2.06B | $2.09B | $1.98B | $2.00B | $2.19B | $2.01B | $1.87B | $2.05B | $2.22B | $1.75B | $1.77B | $2.43B | $1.80B | |
| Operating Income | $740M | $-950M | $474M | $619M | $444M | $276M | $558M | $318M | $389M | $281M | $362M | $14M | $412M | $175M | $-236M | $244M | |
| Interest Income | $11M | $10M | $9M | $15M | $13M | $11M | $9M | $7M | $8M | $9M | $7M | $6M | $7M | $6M | $6M | $3M | |
| Other Non-op | · | · | · | · | · | · | $-2M | $-225M | $-20M | $0 | $-28M | $-60M | $83M | $-23M | $-29M | $-4M | |
| Pretax Income | $348M | $-1.35B | $56M | $218M | $140M | $-47M | $209M | $-21M | $48M | $-69M | $-7M | $-326M | $79M | $-136M | $-357M | $439M | |
| Income Tax | $88M | $77M | $159M | $37M | $12M | $39M | $111M | $71M | $49M | $8M | $40M | $56M | $52M | $73M | $53M | $36M | |
| Net Income | $258M | $-1.42B | $-112M | $179M | $148M | $-58M | $93M | $-85M | $10M | $-64M | $-39M | $-378M | $26M | $-201M | $-410M | $399M | |
| EPS (Basic) | $0.69 | $-3.82 | $-0.30 | $0.48 | $0.40 | $-0.16 | $0.24 | $-0.23 | $0.03 | $-0.17 | $-0.11 | $-1.03 | $0.07 | $-0.55 | $-1.13 | $1.10 | |
| EPS (Diluted) | $0.68 | $-3.82 | $-0.30 | $0.48 | $0.40 | $-0.16 | $0.24 | $-0.23 | $0.03 | $-0.17 | $-0.11 | $-1.03 | $0.07 | $-0.55 | $-1.13 | $1.10 | |
| Shares (Basic) | 375,000,000 | 372,800,000 | · | 371,300,000 | 370,900,000 | 369,600,000 | · | 368,400,000 | 367,900,000 | 366,800,000 | · | 365,400,000 | 364,800,000 | 363,300,000 | · | 362,500,000 | |
| Shares (Diluted) | 378,100,000 | 372,800,000 | · | 375,500,000 | 373,100,000 | 369,600,000 | · | 368,400,000 | 370,200,000 | 366,800,000 | · | 365,400,000 | 367,100,000 | 363,300,000 | · | 363,400,000 | |
| EBITDA | $740M | $-950M | · | $619M | $444M | $276M | · | $318M | $389M | $281M | · | $14M | $412M | $175M | · | $244M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.82B | $1.30B | $1.31B | $1.31B | $1.73B | $1.13B | $1.18B | $719M | $595M | $733M | $947M | $760M | $579M | $518M | $564M | $486M | |
| Receivables | $2.26B | $2.19B | $2.35B | $2.42B | $2.21B | $2.07B | $2.14B | $2.09B | $2.10B | $2.05B | · | $1.95B | $1.74B | $1.69B | · | $1.74B | |
| Inventory | $1.60B | $1.60B | $1.63B | $1.60B | $1.66B | $1.61B | $1.59B | $1.66B | $1.61B | $1.64B | · | $1.27B | $1.24B | $1.22B | · | $1.06B | |
| Prepaid Expense | $819M | $874M | $852M | $894M | $906M | $890M | $838M | $852M | $874M | $957M | · | $1.05B | $890M | $796M | · | $718M | |
| Current Assets | $6.52B | $5.98B | $6.16B | $6.25B | $6.51B | $5.73B | $5.77B | $5.35B | $5.21B | $5.40B | · | $5.05B | $4.46B | $4.24B | · | $4.01B | |
| PP&E (Net) | · | · | $2.07B | $2.03B | $1.99B | $1.88B | $1.78B | $1.79B | $1.74B | $1.71B | · | $1.58B | $1.60B | $1.60B | · | $1.51B | |
| PP&E (Gross) | · | · | $4.50B | · | · | · | $3.92B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $2.42B | · | · | · | $2.14B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $9.79B | $9.81B | $11.27B | $11.29B | $11.30B | $11.15B | $11.09B | $11.17B | $11.13B | $11.16B | $11.18B | $11.19B | $11.63B | $11.58B | $11.55B | $12.04B | |
| Intangibles | $4.18B | $4.40B | $4.64B | $4.83B | $5.05B | $5.30B | $5.55B | $5.65B | $5.90B | $6.18B | · | $6.73B | $5.30B | $5.55B | · | $6.02B | |
| Other Non-current Assets | $358M | $369M | $378M | $382M | $388M | $380M | $363M | $389M | $329M | $312M | · | $328M | $325M | $318M | · | $341M | |
| Total Assets | $24.79B | $24.50B | $26.37B | $26.82B | $27.27B | $26.42B | $26.52B | $26.54B | $26.50B | $26.91B | · | $27.06B | $25.50B | $25.45B | · | $26.30B | |
| Accounts Payable | $593M | $593M | $600M | $616M | $627M | $620M | $589M | $667M | $579M | $642M | · | $569M | $515M | $561M | · | $486M | |
| Accrued Liabilities | $3.07B | $3.04B | $3.34B | $3.60B | $3.47B | $3.35B | $3.49B | $3.39B | $3.34B | $3.23B | · | $3.12B | $3.01B | $2.92B | · | $2.93B | |
| Current Liabilities | $4.54B | $4.53B | $4.18B | $4.79B | $4.97B | $4.26B | $6.75B | $4.51B | $4.37B | $4.41B | · | $4.22B | $3.97B | $3.92B | · | $3.83B | |
| Capital Leases | · | · | $167M | · | · | · | $165M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $211M | $179M | $147M | $145M | $144M | $134M | $128M | $169M | $170M | $170M | · | $213M | $215M | $205M | · | $422M | |
| Other Non-current Liabilities | $733M | $763M | $793M | $843M | $877M | $761M | $713M | $805M | $745M | $751M | · | $721M | $745M | $746M | · | $619M | |
| Total Liabilities | $25.60B | $25.58B | $25.99B | $26.47B | $27.12B | $26.66B | $26.84B | $26.78B | $26.72B | $27.09B | · | $27.30B | $25.23B | $25.30B | · | $25.86B | |
| Long-term Debt | $20.74B | $20.76B | $20.82B | $21.04B | $21.74B | $21.51B | $21.62B | $21.51B | $21.66B | $22.07B | · | $22.43B | $20.55B | $20.65B | · | $21.21B | |
| Total Debt | $20.74B | $20.76B | · | $21.04B | $21.74B | $21.51B | · | $21.51B | $21.66B | $22.07B | · | $22.43B | $20.55B | $20.65B | · | $21.21B | |
| Common Stock | $10.54B | $10.54B | $10.52B | $10.52B | $10.51B | $10.51B | $10.49B | $10.49B | $10.48B | $10.48B | · | $10.42B | $10.41B | $10.40B | · | $10.39B | |
| Retained Earnings | $-10.83B | $-11.09B | $-9.67B | $-9.55B | $-9.73B | $-9.88B | $-9.82B | $-9.92B | $-9.83B | $-9.84B | · | $-9.74B | $-9.36B | $-9.39B | · | $-8.78B | |
| AOCI | $-1.82B | $-1.81B | $-1.76B | $-1.80B | $-1.79B | $-2.03B | $-2.18B | $-1.95B | $-2.01B | $-1.92B | · | $-2.05B | $-1.90B | $-1.99B | · | $-2.27B | |
| Stockholders' Equity | $-1.77B | $-2.06B | $-554M | $-565M | $-764M | $-1.18B | $-1.28B | $-1.17B | $-1.18B | $-1.11B | · | $-1.18B | $-663M | $-800M | · | $-525M | |
| Liabilities + Equity | $24.79B | $24.50B | $26.37B | $26.82B | $27.27B | $26.42B | $26.52B | $26.54B | $26.50B | $26.91B | · | $27.06B | $25.50B | $25.45B | · | $26.30B | |
| Shares Outstanding | 373,901,440 | 373,464,760 | 370,531,987 | 370,473,221 | 369,749,489 | 369,539,455 | 367,843,058 | 367,695,267 | 366,985,967 | 366,674,264 | · | 365,043,317 | 364,063,514 | 363,607,062 | · | 361,781,292 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $281M | $295M | $290M | $306M | $307M | $305M | $307M | $322M | $318M | $320M | $329M | $301M | $315M | $319M | $360M | $335M | |
| Stock-based Comp | $54M | $52M | $84M | $43M | $46M | $43M | $43M | $38M | $36M | $33M | $29M | $29M | $33M | $41M | $35M | $33M | |
| Operating Cash Flow | $670M | $230M | $495M | $405M | $289M | $211M | $601M | $405M | $380M | $211M | $390M | $282M | $206M | $154M | $475M | $-1.26B | |
| CapEx | $77M | $109M | $92M | $91M | $99M | $115M | $106M | $71M | $78M | $82M | $98M | $42M | $28M | $47M | $66M | $54M | |
| Investing Cash Flow | $-93M | $-139M | $-282M | $-83M | $-100M | $-130M | $-200M | $-102M | $-79M | $-73M | $-148M | $-1.89B | $-30M | $-78M | $-136M | $-53M | |
| Debt Issued | $84M | $2.80B | $133M | $-1M | $10.37B | $50M | $506M | $0 | $80M | $75M | $146M | $2.69B | $300M | $155M | $355M | $161M | |
| Net Debt Issued | · | $-55M | · | · | · | $-118M | · | · | · | $-315M | · | · | · | $-124M | · | · | |
| Financing Cash Flow | $-49M | $-100M | $-235M | $-719M | $358M | $-146M | $85M | $-189M | $-424M | $-340M | $-79M | $1.82B | $-120M | $-142M | $-276M | $-36M | |
| Net Change in Cash | $526M | $-13M | $-15M | $-403M | $586M | $-44M | $451M | $127M | $-132M | $-207M | $182M | $192M | $57M | $-60M | $94M | $-1.38B | |
| Free Cash Flow | · | $121M | · | · | · | $96M | · | · | · | $129M | · | · | · | $107M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 25.9% | -37.6% | · | 23.1% | 17.5% | 12.2% | · | 12.7% | 16.2% | 13.1% | · | 0.63% | 19.0% | 9.0% | · | 11.9% | |
| Net Margin | 9.0% | -56.4% | · | 6.7% | 5.9% | -2.6% | · | -3.4% | 0.42% | -3.0% | · | -16.9% | 1.2% | -10.3% | · | 19.5% | |
| Pretax Margin | 12.2% | -53.6% | · | 8.1% | 5.5% | -2.1% | · | -0.84% | 2.0% | -3.2% | · | -14.6% | 3.6% | -7.0% | · | 21.5% | |
| EBITDA Margin | 25.9% | -37.6% | · | 23.1% | 17.5% | 12.2% | · | 12.7% | 16.2% | 13.1% | · | 0.63% | 19.0% | 9.0% | · | 11.9% | |
| ROA | 0.99% | -5.6% | · | 0.67% | 0.55% | -0.22% | · | -0.32% | 0.04% | -0.24% | · | -1.4% | 0.10% | -0.74% | · | 1.4% | |
| ROE | -20.4% | 87.8% | · | -20.6% | -15.3% | 5.1% | · | 7.2% | -1.1% | 6.7% | · | 44.3% | -3.8% | 39.6% | · | -109.5% | |
| ROIC | 2.9% | -5.4% | · | 2.5% | 1.9% | 2.5% | · | 6.9% | -0.04% | 1.5% | · | 0.08% | 0.71% | 1.4% | · | 1.1% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.3 | · | 1.3 | 1.3 | 1.3 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.1 | 1.1 | · | 1.0 | |
| Quick Ratio | 0.9 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | -11.7 | -10.1 | · | -37.2 | -28.5 | -18.2 | · | -18.3 | -18.4 | -19.8 | · | -19.0 | -31.0 | -25.8 | · | -40.4 | |
| LT Debt / Equity | -11.2 | -9.7 | · | -36.2 | -27.3 | -17.9 | · | -17.9 | -18.0 | -19.3 | · | -18.6 | -30.3 | -25.3 | · | -39.6 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.3 | 1.2 | · | 1.2 | 1.2 | 1.1 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.3 | 1.2 | · | 1.2 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-4.74 | $-5.51 | · | $-1.53 | $-2.07 | $-3.20 | · | $-3.19 | $-3.20 | $-3.04 | · | $-3.23 | $-1.82 | $-2.20 | · | $-1.45 | |
| Revenue / Share | $7.54 | $6.77 | · | $7.14 | $6.78 | $6.11 | · | $6.81 | $6.49 | $5.87 | · | $6.12 | $5.90 | $5.35 | · | $5.63 | |
| Cash Flow / Share | · | $0.62 | · | · | · | $0.57 | · | · | · | $0.58 | · | · | · | $0.42 | · | · | |
| Cash / Share | $4.88 | $3.48 | · | $3.53 | $4.67 | $3.07 | · | $1.96 | $1.62 | $2.00 | · | $2.08 | $1.59 | $1.42 | · | $1.34 | |
| EPS (TTM) | $-2.96 | $-3.24 | · | $0.96 | $0.25 | $-0.12 | · | $-0.48 | $-1.28 | $-1.24 | · | $-2.64 | $-0.51 | $-0.98 | · | $0.72 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10.85B | $10.53B | · | $10.03B | $9.86B | $9.73B | · | $9.47B | $9.20B | $8.97B | · | $8.54B | $8.35B | $8.15B | · | $8.13B | |
| Net Income TTM | $-1.10B | $-1.21B | · | $362M | $98M | $-40M | · | $-178M | $-471M | $-455M | · | $-963M | $-186M | $-357M | · | $254M | |
| Market Cap | $1.84B | $2.02B | · | $2.39B | $2.46B | $2.39B | · | $3.00B | $2.56B | $3.89B | · | $3.00B | $2.91B | $2.95B | · | $2.49B | |
| Enterprise Value | $20.76B | $21.48B | · | $22.12B | $22.47B | $22.77B | · | $23.79B | $23.62B | $25.23B | · | $24.67B | $22.89B | $23.08B | · | $23.22B | |
| P/E | -1.7 | -1.7 | · | 6.7 | 26.6 | -53.9 | · | -17.0 | -5.4 | -8.6 | · | -3.1 | -15.7 | -8.3 | · | 9.6 | |
| P/S | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.3 | 0.4 | · | 0.3 | |
| P/B | -1.0 | -1.0 | · | -4.2 | -3.2 | -2.0 | · | -2.6 | -2.2 | -3.5 | · | -2.5 | -4.4 | -3.7 | · | -4.7 | |
| P / Cash Flow | · | 8.8 | · | · | · | 11.3 | · | · | · | 18.4 | · | · | · | 19.1 | · | · | |
| EV / Revenue | 1.9 | 2.0 | · | 2.2 | 2.3 | 2.3 | · | 2.5 | 2.6 | 2.8 | · | 2.9 | 2.7 | 2.8 | · | 2.9 | |
| Earnings Yield | -60.0% | -60.0% | · | 14.9% | 3.8% | -1.8% | · | -5.9% | -18.4% | -11.7% | · | -32.1% | -6.4% | -12.1% | · | 10.4% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $10.27B | $9.62B | $8.76B | $8.12B | $8.43B |
| Faaliyet Kâr Marjı % | 17.7% | 16.1% | 11.0% | 5.6% | 5.3% |
| Net Gelir | $157M | $-46M | $-592M | $-225M | $-948M |
| Seyreltilmiş Hisse Başı Kâr | $0.42 | $-0.13 | $-1.62 | $-0.62 | $-2.64 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | -37.6 | -16.9 | -21.9 | -30.0 | -213.7 |
| Cari Oran | 1.5 | 0.9 | 1.3 | 1.1 | 1.1 |
| Cari Oran | 0.9 | 0.5 | 0.7 | 0.6 | 0.5 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $1.00B | $1.26B | $817M | $-946M | $1.16B |
Kurumsal Sahipler (13F) 262 dosya · $1.3B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
262
Tutulan Değer
$1.3B
Yeni pozisyonlar
28
Çıkan pozisyonlar
30
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 28 (-5 önceki Ç'ye göre) | 30 (0 önceki Ç'ye göre) | 78 (-11 önceki Ç'ye göre) | 72 (+6 önceki Ç'ye göre) | +11.6M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| PAULSON & CO. INC. | $361.151.434 | 73.255.869 | 28,47% | Hisse senetleri |
| GOLDENTREE ASSET MANAGEMENT LP | $170.706.865 | 34.665.731 | 13,46% | Hisse senetleri |
| VANGUARD GROUP INC | $74.149.574 | 10.679.760 | 5,85% | Hisse senetleri |
| ROYAL BANK OF CANADA | $53.404.000 | 10.832.582 | 4,21% | Hisse senetleri |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $39.440.000 | 8.000.000 | 3,11% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $36.797.292 | 7.465.468 | 2,90% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $33.169.671 | 4.803.485 | 2,61% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $30.689.896 | 6.225.131 | 2,42% | Hisse senetleri |
| MFN Partners Management, LP | $29.580.000 | 6.000.000 | 2,33% | Hisse senetleri |
| Kohlberg Kravis Roberts & Co. L.P. | $25.808.550 | 5.235.000 | 2,03% | Hisse senetleri |
| ING GROEP NV | $24.650.000 | 5.000.000 | 1,94% | Hisse senetleri |
| Hudson Bay Capital Management LP | $24.650.000 | 5.000.000 | 1,94% | Hisse senetleri |
| GENDELL JEFFREY L | $19.902.859 | 4.037.091 | 1,57% | Hisse senetleri |
| Lombard Odier Asset Management (USA) Corp | $19.720.000 | 4.000.000 | 1,55% | Satım opsiyonu |
| NORGES BANK | $16.914.543 | 3.431.117 | 1,33% | Hisse senetleri |
| MACQUARIE GROUP LTD | $16.022.500 | 3.250.000 | 1,26% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $15.976.544 | 3.241.140 | 1,26% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $13.258.130 | 2.689.942 | 1,05% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $11.094.735 | 2.250.910 | 0,87% | Hisse senetleri |
| Point72 Asset Management, L.P. | $11.021.637 | 2.235.821 | 0,87% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $10.771.345 | 2.186.244 | 0,85% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $10.528.419 | 2.135.582 | 0,83% | Hisse senetleri |
| PRIVATE MANAGEMENT GROUP INC | $8.301.316 | 1.683.837 | 0,65% | Hisse senetleri |
| Qube Research & Technologies Ltd | $8.291.856 | 1.681.918 | 0,65% | Hisse senetleri |
| BARCLAYS PLC | $8.134.500 | 1.650.000 | 0,64% | Satım opsiyonu |
| TWO SIGMA ADVISERS, LP | $7.366.576 | 1.059.939 | 0,58% | Hisse senetleri |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $7.365.406 | 1.494.205 | 0,58% | Hisse senetleri |
| Man Group plc | $7.157.280 | 1.451.781 | 0,56% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.903.479 | 1.400.300 | 0,54% | Satım opsiyonu |
| RENAISSANCE TECHNOLOGIES LLC | $6.530.027 | 1.324.549 | 0,51% | Hisse senetleri |
| MORGAN STANLEY | $6.174.733 | 1.252.481 | 0,49% | Hisse senetleri |
| CITADEL ADVISORS LLC | $5.447.922 | 1.105.055 | 0,43% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $5.394.096 | 1.095.104 | 0,43% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.138.046 | 1.042.200 | 0,41% | Alım opsiyonu |
| DEUTSCHE BANK AG\ | $4.930.000 | 1.000.000 | 0,39% | Alım opsiyonu |
| BANK OF MONTREAL /CAN/ | $4.856.469 | 986.351 | 0,38% | Hisse senetleri |
| TD Asset Management Inc | $4.624.904 | 938.710 | 0,36% | Hisse senetleri |
| SIG North Trading, ULC | $4.360.585 | 884.500 | 0,34% | Alım opsiyonu |
| JPMORGAN CHASE & CO | $4.272.070 | 880.839 | 0,34% | Hisse senetleri |
| Bridgewater Associates, LP | $4.270.785 | 866.285 | 0,34% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $4.217.745 | 855.700 | 0,33% | Hisse senetleri |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $3.712.320 | 753.006 | 0,29% | Hisse senetleri |
| UBS Group AG | $3.668.940 | 744.207 | 0,29% | Hisse senetleri |
| CITADEL ADVISORS LLC | $3.660.525 | 742.500 | 0,29% | Satım opsiyonu |
| GAMCO INVESTORS, INC. ET AL | $3.486.772 | 707.256 | 0,27% | Hisse senetleri |
| WHITEBOX ADVISORS LLC | $3.030.333 | 614.672 | 0,24% | Hisse senetleri |
| Jump Financial, LLC | $3.012.723 | 611.100 | 0,24% | Hisse senetleri |
| TORONTO DOMINION BANK | $2.916.546 | 592.351 | 0,23% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $2.815.928 | 571.182 | 0,22% | Hisse senetleri |
| WOLVERINE ASSET MANAGEMENT LLC | $2.680.441 | 543.700 | 0,21% | Satım opsiyonu |
Aktivistler ve %5+ sahipler 28 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Icahn Partners Master Fund LP, Icahn Offshore LP, Icahn Partners LP, Icahn Onshore LP, Icahn Capital LP, IPH GP LLC, Icahn Enterprises Holdings L.P., Icahn Enterprises G.P. Inc., Beckton Corp., Carl C. Icahn ×6 başvurular | 15 Ağustos 2025 | 0,00% | Değişiklik | · | SEC |
| PAULSON & CO. INC. ×6 başvurular | 14 Ağustos 2025 | 19,10% | Değişiklik | · | SEC |
| Alex Meruelo | 07 Nisan 2025 | 9,99% | İlk başvuru | Pasif yatırım | SEC |
| 19 Ağustos 2024 | · | İlk başvuru | · | SEC | |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 13 Mayıs 2022 | · | İlk başvuru | · | SEC |
| Glenview Capital Management, LLC, Larry Robbins ×2 başvurular | 13 Aralık 2021 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 21 Haziran 2021 | · | İlk başvuru | Yönetim kurulu kampanyası | SEC |
| 24 Şubat 2021 | · | İlk başvuru | · | SEC | |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 16 Mart 2017 | · | İlk başvuru | Pasif yatırım | SEC |
| Pershing Square Capital Management, L.P., PS Management GP, LLC, William A. Ackman ×12 başvurular | 14 Mart 2017 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 15 Haziran 2015 | · | İlk başvuru | · | SEC |
| Valeant Pharmaceuticals International, Inc., Valeant Pharmaceuticals International ×10 başvurular | 20 Kasım 2014 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 25 Eylül 2014 | · | İlk başvuru | Pasif yatırım | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 08 Mayıs 2014 | · | İlk başvuru | Yönetim kurulu kampanyası | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 23 Mayıs 2012 | · | İlk başvuru | Pasif yatırım | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 23 Mayıs 2011 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 11 Mayıs 2011 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 01 Mart 2011 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 06 Ekim 2010 | · | İlk başvuru | M&A / satış | SEC |
| Açıklanmayan raporlama kişisi | 29 Haziran 2010 | · | İlk başvuru | M&A / satış | SEC |
| Eugene Melnyk ×3 başvurular | 22 Mart 2010 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 23 Ocak 2004 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 10 Kasım 2003 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 19 Ağustos 2003 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 12 Aralık 2002 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 08 Mayıs 2002 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 15 Ocak 2002 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 28 Eylül 2001 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 79 içeriden öğrenenler · 37 yöneticiler · 41 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Thomas Appio | Chief Executive Officer | 02 Mart 2026 J | 2.315.374 | 0 | 0 | $0 |
| Howard Bradley Schiller | Chairman and CEO | 18 Şubat 2016 F | 336.784 | 0 | 0 | $0 |
| Michael J. Pearson | Chief Executive Officer | 31 Aralık 2015 F | 1.514.664 | 0 | 0 | $0 |
| Jean-Jacques Charhon | EVP, CFO | 27 Şubat 2026 F | 706.478 | 0 | 0 | $0 |
| Tom George Vadaketh | EVP, Chief Financial Officer | 05 Eylül 2023 F | 564.933 | 0 | 0 | $0 |
| Sam Eldessouky | EVP & Chief Financial Officer | 03 Mart 2022 F | 119.455 | 0 | 0 | $0 |
| Philip Walden Loberg Jr | EVP, Interim CFO | 25 Temmuz 2011 A | 145.065 | 0 | 0 | $0 |
| Margaret Jean Mulligan | EVP, CFO | 11 Kasım 2010 A | 83.014 | 0 | 0 | $0 |
| Aimee J. Lenar | President, US Pharma | 19 Ağustos 2026 S | 334.853 | 0 | 1 | $-258.894 |
| Robert Spurr | President, U.S. Businesses | 10 Mayıs 2022 M | 112.741 | 0 | 0 | $0 |
| William D. Humphries | President, Ortho-Dermatologics | 04 Aralık 2020 M | 235.035 | 0 | 0 | $0 |
| Mark C. Mckenna | President, Salix | 19 Ağustos 2019 S | 20.756 | 0 | 0 | $0 |
| Rajiv De Silva | President and COO | 05 Ocak 2013 F | 259.767 | 0 | 0 | $0 |
| Richard Kevin Masterson | Pres. & COO, Valeant Intl. BB | 10 Mayıs 2012 S | 89.524 | 0 | 0 | $0 |
| Michel Chouinard | COO, Biovail Labs. Intl SRL | 22 Aralık 2010 A | 2.470 | 0 | 0 | $0 |
| Gilbert Godin | EVP & COO | 05 Temmuz 2010 A | · | 0 | 0 | $0 |
| Steven Hyosig Lee | SVP, Controller & CAO | 14 Temmuz 2026 F | 70.114 | 0 | 0 | $0 |
| Seana Carson | EVP, General Counsel | 03 Mart 2026 S | 616.761 | 0 | 3 | $-115.040 |
| John S Barresi | SVP, Controller & CAO | 28 Şubat 2025 F | 192.268 | 0 | 0 | $0 |
| Frederick Munsch | SVP, Controller and CAO | 03 Mayıs 2022 F | 22.435 | 0 | 0 | $0 |
| Christina Ackermann | EVP AND GENERAL COUNSEL | 10 Mart 2022 F | 162.240 | 0 | 0 | $0 |
| Joseph F Gordon | Pres&Co-Head Bausch&Lomb/Int'l | 08 Mart 2022 S | 93.139 | 0 | 0 | $0 |
| Robert L. Rosiello | EVP, Corp Dev & Strategy | 05 Aralık 2016 F | 517.683 | 0 | 0 | $0 |
| Ari Kellen | EVP, Company Group Chairman | 05 Aralık 2016 F | 630.842 | 0 | 0 | $0 |
| Anne Clem Whitaker | EVP, Company Group Chairman | 05 Aralık 2016 F | 158.544 | 0 | 0 | $0 |
| Robert Roswell Chai-Onn | EVP, CLO, General Counsel | 12 Mayıs 2016 A | 124.815 | 0 | 0 | $0 |
| Debora Jorn | EVP, Company Group Chairman | 20 Kasım 2015 F | 34.812 | 0 | 0 | $0 |
| Pavel Mirovsky | EVP, Pres. & GM Valeant EMENA | 23 Haziran 2015 A | 69.525 | 0 | 0 | $0 |
| Brian M. Stolz | EVP, Administration & CHCO | 22 Haziran 2015 F | 125.280 | 0 | 0 | $0 |
| Laizer Kornwasser | EVP, Company Group Chairman | 27 Nisan 2015 D | 98.824 | 0 | 0 | $0 |
| Daniel Mark Wechsler | EVO, Co. Grp. Chmn, Eye Health | 12 Ağustos 2013 A | · | 0 | 0 | $0 |
| Susan Hall | Global Head of R&D | 26 Temmuz 2013 M | 27.588 | 0 | 0 | $0 |
| Jason David Hanson | EVP, Company Group Chairman | 11 Aralık 2012 A | · | 0 | 0 | $0 |
| Mark Andrew Durham | SVP Human Resources | 11 Mayıs 2011 M | 61.595 | 0 | 0 | $0 |
| Christine Mayer | SVP, BTA Pharmaceuticals, Inc. | 04 Ekim 2010 A | 0 | 0 | 0 | $0 |
| Hans Christian Fibiger | Chief Scientific Officer | 04 Ekim 2010 A | 0 | 0 | 0 | $0 |
| Gregory David Gubitz | SVP, Corp. Devel. & GC | 05 Temmuz 2010 A | · | 0 | 0 | $0 |
| Amy B Wechsler | Yönetim kurulu üyesi | 30 Eylül 2026 A | 316.158 | 0 | 0 | $0 |
| John Paulson | Yönetim kurulu üyesi | 30 Eylül 2026 A | 440.962 | 0 | 0 | $0 |
| Sandra Leung | Yönetim kurulu üyesi | 30 Eylül 2026 A | 102.859 | 0 | 0 | $0 |
| Frank D. Lee | Yönetim kurulu üyesi | 22 Mayıs 2026 A | 95.210 | 0 | 1 | $-132.796 |
| Michael Goettler | Yönetim kurulu üyesi | 22 Mayıs 2026 A | 76.020 | 0 | 0 | $0 |
| Eiry Roberts | Yönetim kurulu üyesi | 22 Mayıs 2026 A | 45.871 | 0 | 0 | $0 |
| Sarah B Kavanagh | Yönetim kurulu üyesi | 22 Mayıs 2026 A | 282.230 | 0 | 0 | $0 |
| Christian A Garcia | Yönetim kurulu üyesi | 22 Mayıs 2026 A | 135.578 | 0 | 0 | $0 |
| Robert N Power | Yönetim kurulu üyesi | 22 Mayıs 2026 A | 300.594 | 0 | 0 | $0 |
| Brett Icahn | Yönetim kurulu üyesi | 30 Haziran 2025 A | 220.280 | 0 | 0 | $0 |
| Steven D Miller | Yönetim kurulu üyesi | 16 Mayıs 2025 A | 229.224 | 0 | 0 | $0 |
| Richard Mulligan | Yönetim kurulu üyesi | 16 Mayıs 2025 A | 155.616 | 0 | 0 | $0 |
| Russel C Robertson | Yönetim kurulu üyesi | 29 Mart 2024 A | 225.279 | 0 | 0 | $0 |
| Thomas W. Ross Sr. | Yönetim kurulu üyesi | 19 Mayıs 2023 A | 161.516 | 0 | 0 | $0 |
| Richard U De Schutter | Yönetim kurulu üyesi | 31 Mart 2023 A | 373.407 | 0 | 0 | $0 |
| Argeris N Karabelas | Yönetim kurulu üyesi | 24 Haziran 2022 A | 123.715 | 0 | 0 | $0 |
| Joseph C Papa | Yönetim kurulu üyesi | 10 Mayıs 2022 M | 1.427.568 | 0 | 0 | $0 |
| Fredric N Eshelman | Yönetim kurulu üyesi | 05 Mayıs 2017 A | 38.298 | 0 | 0 | $0 |
| Robert Alexander Ingram | Yönetim kurulu üyesi | 31 Mart 2017 A | 92.046 | 0 | 0 | $0 |
| Ronald Harold Farmer | Yönetim kurulu üyesi | 02 Mayıs 2016 A | 38.447 | 0 | 0 | $0 |
| Norma Ann Provencio | Yönetim kurulu üyesi | 02 Mayıs 2016 A | 144.899 | 0 | 0 | $0 |
| Kyriazi Theo Melas | Yönetim kurulu üyesi | 02 Mayıs 2016 A | 223.087 | 0 | 0 | $0 |
| Anders Lonner | Yönetim kurulu üyesi | 26 Mayıs 2015 F | 29.891 | 0 | 0 | $0 |
| Katharine Berghuis Stevenson | Yönetim kurulu üyesi | 22 Mayıs 2015 A | 24.705 | 0 | 0 | $0 |
| Colleen A Goggins | Yönetim kurulu üyesi | 22 Mayıs 2015 A | 4.973 | 0 | 0 | $0 |
| Fred Hassan | Yönetim kurulu üyesi | 29 Ağustos 2013 P | 53.969 | 0 | 0 | $0 |
| Lloyd Mitchell Segal | Yönetim kurulu üyesi | 14 Haziran 2013 P | 21.174 | 0 | 0 | $0 |
| Mason G Morfit | Yönetim kurulu üyesi | 04 Haziran 2012 A | 81.106 | 0 | 0 | $0 |
| Laurence E Paul | Yönetim kurulu üyesi | 01 Haziran 2012 P | 60.459 | 0 | 0 | $0 |
| Michael Robert Van Every | Yönetim kurulu üyesi | 19 Mayıs 2011 A | 6.397 | 0 | 0 | $0 |
| William Mcdowall Wells | Yönetim kurulu üyesi | 07 Aralık 2010 M | 75.000 | 0 | 0 | $0 |
| Louis Randall Tull | Yönetim kurulu üyesi | 05 Temmuz 2010 A | · | 0 | 0 | $0 |
| Douglas John Paul Squires | Yönetim kurulu üyesi | 05 Temmuz 2010 A | 29.688 | 0 | 0 | $0 |
| John Spencer Lanthier | Yönetim kurulu üyesi | 05 Temmuz 2010 A | · | 0 | 0 | $0 |
| Frank Potter | Yönetim kurulu üyesi | 05 Temmuz 2010 A | · | 0 | 0 | $0 |
| David H. Laidley | Yönetim kurulu üyesi | 05 Temmuz 2010 A | · | 0 | 0 | $0 |
| Mark W Parrish | Yönetim kurulu üyesi | 05 Temmuz 2010 A | · | 0 | 0 | $0 |
| GOUIN SERGE | Yönetim kurulu üyesi | 05 Temmuz 2010 A | · | 0 | 0 | $0 |
| PAULSON & CO. INC. | 10% sahip | 25 Kasım 2025 P | 73.255.869 | 1 | 0 | $15.625.000 |
| Andrew C. Von Eschenbach | · | 05 Ağustos 2021 P | 38.647 | 0 | 0 | $0 |
| Paul Herendeen | · | 08 Mart 2021 M | 386.618 | 0 | 0 | $0 |
| Ryan Weldon | · | 28 Nisan 2014 M | 103.409 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 18 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| TLTD · FlexShares Trust | 0,08% | 78.045 NS | 31 Temmuz 2026 | N-PORT |
| ISCF · iShares Trust | 0,07% | 79.984 SH | 11 Eylül 2026 | Günlük |
| DFIS · Dimensional ETF Trust | 0,04% | 336.568 NS | 31 Temmuz 2026 | N-PORT |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 978.582 SH | 19 Ağustos 2026 | Günlük |
| DISV · Dimensional ETF Trust | 0,03% | 214.485 NS | 31 Temmuz 2026 | N-PORT |
| DXIV · Dimensional ETF Trust | 0,03% | 7.943 NS | 31 Temmuz 2026 | N-PORT |
| PXF · Invesco Exchange-Traded Fund Trust … | 0,02% | 120.464 SH | 01 Ekim 2026 | Günlük |
| WSML · iShares Trust | 0,02% | 16.543 SH | 10 Eylül 2026 | Günlük |
| DFSI · Dimensional ETF Trust | 0,01% | 23.138 NS | 31 Temmuz 2026 | N-PORT |
| DFIC · Dimensional ETF Trust | 0,01% | 234.253 NS | 31 Temmuz 2026 | N-PORT |
| DFAX · Dimensional ETF Trust | 0,01% | 120.510 NS | 31 Temmuz 2026 | N-PORT |
| IDEV · iShares Trust | 0,01% | 364.677 SH | 11 Eylül 2026 | Günlük |
| IXUS · iShares Trust | 0,00% | 379.290 SH | 11 Eylül 2026 | Günlük |
| DFAI · Dimensional ETF Trust | 0,00% | 88.488 NS | 31 Temmuz 2026 | N-PORT |
| VXUS · VANGUARD STAR FUNDS | 0,00% | 3.762.192 SH | 19 Ağustos 2026 | Günlük |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 190.882 SH | 19 Ağustos 2026 | Günlük |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,00% | 2.481.313 SH | 19 Ağustos 2026 | Günlük |
| VSGX · VANGUARD WORLD FUND | 0,00% | 52.499 SH | 19 Ağustos 2026 | Günlük |
BHC Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 8 analist
SAT
Medyan hedef
$7.00
+20,7%
0 0,0%
Güçlü Al
0 0,0%
Al
4 50,0%
Tut
3 37,5%
Sat
1 12,5%
Güçlü Sat
12 Aylık Fiyat Hedefi
5 analist · 2026-10-03Ortalama hedef $7.50 +29,3%
← Tüm hedeflerin altında
Mevcut fiyat $5.80
Düşük$6.50
Ortalama$7.50
Yüksek$9.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| BHC | $2.58B | 16.5 | 6.7% | 1.5% | -17.1% | · |
| TLRY | $726M | -5.1 | 11.5% | -13.3% | -7.8% | 28.4% |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Tem 30, 2026